Diagnosis and treatment of chronic rhinosinusitis: Focus on intranasal Amphotericin B

Therapeutics and Clinical Risk Management

Volumn 3, Issue 2, 2007, Pages 319-325

  Kern, Eugene B ^a   Sherris, David ^a   Stergiou, Angelos M ^b   Katz, Laura M ^b   Rosenblatt, Lisa C ^c   Ponikau, Jens ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Accentia Biopharmaceuticals   (United States)

^c Analytica International   (United States)

Author keywords

Amphotericin B; Antifungal; Chronic sinusitis; Diagnosis; Rhinosinusitis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR BASIC PROTEIN; MUCIN; SODIUM CHLORIDE;

ALLERGIC RHINITIS; ALTERNARIA; ANTIBIOTIC RESISTANCE; ATOPY; BURNING SENSATION; CELL GRANULE; CELL INFILTRATION; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; CYTOLOGY; DEGRANULATION; DESENSITIZATION; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SURGERY; ENDOSCOPY; EOSINOPHIL; EVIDENCE BASED MEDICINE; FUNGICIDAL ACTIVITY; FUNGUS HYPHAE; FUSOBACTERIUM; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LAVAGE; NASAL BIOPSY; NOSE MUCOSA; NOSE MUCUS; NOSE OBSTRUCTION; NOSE POLYP; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT CARE; PEPTOSTREPTOCOCCUS; PREVOTELLA; PROTEIN SECRETION; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; RHINOSINUSITIS; SENSITIVITY AND SPECIFICITY; SKULL RADIOGRAPHY; STAPHYLOCOCCUS; SYMPTOM; TH2 CELL; TISSUE INJURY; TREATMENT OUTCOME; UNITED STATES;

EID: 34250026417     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: 10.2147/tcrm.2007.3.2.319     Document Type: Review

References (24)

1. [AmB PI] 1996. Fungizone oral suspension (Amphotericin B) (complete prescribing information) Bristol-Myers Squibb Co.
2. Benninger MS, Ferguson BJ, Hadley JA, et al. 2003. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg, 129(3 Suppl):S1-32.
3. Frigas E, Loegering DA, Gleich GJ. 1980. Cytotoxic effects of the guinea-pig eosinophil major basic protein on tracheal epithelium. Lab Invest, 42:35-43.
4. Gleich GJ, Adolphson CR, Leiferman KM. 1993. The biology of the eosinophilic leukocyte. Annu Rev Med, 44:85-101.
5. Gosepath J, Brieger J, Vlachtsis K, et al. 2004. Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol, 18(1):9-13.
6. Groll AH, Gea-Banacloche JC, Glasmacher A, et al. 2003. Clinical pharmacology of antifungal compounds. Infect Dis Clin North Am, 17:159-91, ix.
7. Hamilos DL, Lund VJ. 2004. Etiology of chronic rhinosinusitis: the role of fungus. Ann Otol Rhinol Laryngol Suppl, 193:27-31.
8. Heatley DG, McConnell KE, Kille TL, et al. 2001. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg, 125:44-8.
9. Lethbridge-Çejku M, Rose D, Vickerie J. 2006. Summary health statistics for US. Adults: National Health Interview Survey, 2004. National Center for Health Statistics. Vital Health Stat, 10(228).
10. Lethbridge-Çejku M, Schiller JS, Bernadel L. 2004. Summary health statistics for U.S. Adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat, 10(222).
11. Meltzer EO, Hamilos DL, Hadley JA, et al. 2004. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol, 114(6 Suppl):155-212.
12. Motojima S, Frigas E, Loegering DA, et al. 1989. Toxicity of eosinophil cationic proteins for guinea-pic tracheal epithelium in vitro. Am Rev Res Dis, 139:801-5.
13. Ponikau JU, Sherris DA, Kephart GM, et al. 2005. Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol, 116:362-9.
14. Ponikau JU, Sherris DA, Kephart GM, et al. 2003. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol, 112:877-82.
15. Ponikau JU, Sherris DA, Kern ED et al. 1999. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc, 74:877-84.
16. Ponikau JU, Sherris DA, Kita H, et al. 2002. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol, 110:862-6.
17. Ponikau JU, Sherris DA, Weaver A, et al. 2005. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol, 115:125-31.
18. Ricchetti A, Landis BN, Maffioli A, et al. 2002. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol, 116:261-3.
19. Sasama J, Sherris DA, Shin SH, et al. 2005. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg, 13:2-8.
20. Slavin RG, Spector SL, Bernstein IL, et al. 2005. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol, 116(6 Suppl):S13-47.
21. Tichenor WS. 2006. Sinusitis for physicians 1998-2006 [online]. Accessed on 15 August 2006. URL: http://www.sinuses.com/ search_site.cgi?fname=md.htm&db=s&skw=diagnosis&method=and.
22. Weschta M, Rimek D, Formanek M, et al. 2004. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. [i J Allergy Clin Immunol i], 113:1122-8.
23. Wise GJ, Kozinn PJ, Goldberg P. 1982. Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. [i J Urol i], 128:82-4.
24. Witterick IJ, Kolenda J. 2004. Surgical management of chronic rhinosinusitis. [i Immunol Allergy Clin North Am i], 24:119-34.